Atrium Therapeutics (RNA)

Atrium Therapeutics (RNA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RNA last traded at $8.54, 3.26% on the day.
• Atrium Therapeutics: market cap $141.46M, P/E -2.2, next earnings 2026-11-12.
• Over the past year RNA returned -87.74%; year to date -88.16%.

Updated 2026-11-03 01:57 UTC